Trials / Terminated
TerminatedNCT03166761
Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection
Randomized Prospective Study of Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Steroid Injection
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Comparing two different corticosteroids (dexamethasone and triamcinolone) for use in sacroiliac joint injections
Detailed description
Patients eligible for a sacroiliac joint injection will be randomized to receive one of two different steroids, dexamethasone or triamcinolone. The response immediately after injection will be assessed to confirm the diagnosis, and then they will be followed for three month to assess the degree of pain relief experienced
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | Dexamethasone injection into the sacroiliac joint |
| DRUG | Triamcinolone Acetonide | Triamcinolone injection into the sacroiliac joint |
Timeline
- Start date
- 2017-09-14
- Primary completion
- 2023-02-28
- Completion
- 2023-02-28
- First posted
- 2017-05-25
- Last updated
- 2024-07-10
- Results posted
- 2024-07-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03166761. Inclusion in this directory is not an endorsement.